These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22008652)

  • 1. Testosterone replacement therapy and polycythemia in HIV-infected patients.
    Vorkas CK; Vaamonde CM; Glesby MJ
    AIDS; 2012 Jan; 26(2):243-5. PubMed ID: 22008652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia.
    Rotker KL; Alavian M; Nelson B; Baird GL; Miner MM; Sigman M; Hwang K
    Asian J Androl; 2018; 20(2):195-199. PubMed ID: 29205178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets.
    Ip FF; di Pierro I; Brown R; Cunningham I; Handelsman DJ; Liu PY
    Eur J Endocrinol; 2010 Feb; 162(2):385-90. PubMed ID: 19903801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study.
    Wheeler KM; Smith RP; Kumar RA; Setia S; Costabile RA; Kavoussi PK
    J Urol; 2017 Apr; 197(4):1127-1131. PubMed ID: 27984109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of polycythaemia induced by intramuscular androgen replacement using transdermal testosterone therapy.
    Siddique H; Smith JC; Corrall RJ
    Clin Endocrinol (Oxf); 2004 Jan; 60(1):143-5. PubMed ID: 14678301
    [No Abstract]   [Full Text] [Related]  

  • 6. [Abdominal pain and hypertension in a 55-year-old male patient].
    Kofler T; Yueksel F; Dirnhofer S; Donath MY; Trendelenburg M
    Internist (Berl); 2017 Apr; 58(4):397-401. PubMed ID: 28005140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocytosis Following Testosterone Therapy.
    Ohlander SJ; Varghese B; Pastuszak AW
    Sex Med Rev; 2018 Jan; 6(1):77-85. PubMed ID: 28526632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Letter.
    Kaplan-Marans E
    J Urol; 2022 Sep; 208(3):566-567. PubMed ID: 35648648
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Reply.
    Ory J; Ramasamy R
    J Urol; 2022 Sep; 208(3):567. PubMed ID: 35648647
    [No Abstract]   [Full Text] [Related]  

  • 10. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 11. Testosterone replacement in elderly men.
    Baum NH; Crespi CA
    Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New modalities of transdermal testosterone replacement.
    Basaria S; Dobs AS
    Treat Endocrinol; 2003; 2(1):1-9. PubMed ID: 15871550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy.
    Barros R
    Int Braz J Urol; 2023; 49(1):150-151. PubMed ID: 36512463
    [No Abstract]   [Full Text] [Related]  

  • 15. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
    Lundy SD; Parekh NV; Shoskes DA
    J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Erythrocytosis During Concomitant Testosterone and SGLT2-Inhibitor Treatment: A Warning From Two Clinical Cases.
    Motta G; Zavattaro M; Romeo F; Lanfranco F; Broglio F
    J Clin Endocrinol Metab; 2019 Mar; 104(3):819-822. PubMed ID: 30395251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jatenzo - an oral testosterone for hypogonadism.
    Med Lett Drugs Ther; 2021 Jun; 63(1627):103-104. PubMed ID: 34181633
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis.
    Aghazadeh M; Pastuszak AW; Johnson WG; McIntyre MG; Hsieh TM; Lipshultz LI
    J Urol; 2015 Jul; 194(1):160-5. PubMed ID: 25596360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short term testosterone replacement therapy improves libido and body composition.
    Andrade ES; Clapauch R; Buksman S
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):996-1004. PubMed ID: 20126853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible aquagenic pruritus associated with testosterone-induced erythrocytosis.
    Liu M; Shinkai K
    J Am Acad Dermatol; 2014 Jun; 70(6):e139-40. PubMed ID: 24831338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.